Walleye Trading
AERI

Walleye Trading’s Aerie Pharmaceuticals AERI Stock Holding History

Walleye Trading’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,000
Closed -$7K – 6143
2021
Q4 		$7K Hold
1,000
– – ﹤0.01% 5173
2021
Q3 		$11K Buy
+1,000
New +$14.6K ﹤0.01% 4986
2020
Q3 		– Sell
-13,000
Closed -$192K – 4796
2020
Q2 		$192K Buy
13,000
+2,500
+24% +$37K ﹤0.01% 3101
2020
Q1 		$142K Sell
10,500
-2,100
-17% -$39.8K ﹤0.01% 2886
2019
Q4 		$305K Buy
12,600
+10,500
+500% +$217K ﹤0.01% 2807
2019
Q3 		$40K Buy
2,100
+1,300
+163% +$29.8K ﹤0.01% 3635
2019
Q2 		$24K Buy
+800
New +$30.8K ﹤0.01% 3711
2018
Q4 		– Sell
-5,600
Closed -$345K – 5529
2018
Q3 		$345K Buy
+5,600
New +$360K ﹤0.01% 3279
2018
Q2 		– Sell
-1,000
Closed -$54K – 5026
2018
Q1 		$54K Sell
1,000
-700
-41% -$39.1K ﹤0.01% 4116
2017
Q4 		$102 Buy
+1,700
New +$103K ﹤0.01% 3821

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Walleye Trading's AERI Position: Q3 2022 in Review

Walleye Trading sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 15,894 shares — an estimated $119K sold.

Walleye Trading first reported a position in AERI in Q2 2015 and held it in 11 quarters. The position peaked at $487K in Q2 2018. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

  • Walleye Trading reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 15,894 Aerie Pharmaceuticals shares in Q3 2022, an estimated $119K.
  • Walleye Trading first reported a position in Aerie Pharmaceuticals in Q2 2015 and held it in 11 quarters.
  • Walleye Trading's Aerie Pharmaceuticals position peaked at $487K in Q2 2018.
  • 156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.